BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20087959)

  • 1. Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk.
    Cremona M; CalabrĂ² E; Randi G; De Bortoli M; Mondellini P; Verri C; Sozzi G; Pierotti MA; La Vecchia C; Pastorino U; Bongarzone I
    Cancer; 2010 Mar; 116(5):1326-35. PubMed ID: 20087959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
    Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
    J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested case-control study: Japan Public Health Center-based prospective study.
    Sasazuki S; Inoue M; Sawada N; Iwasaki M; Shimazu T; Yamaji T; Tsugane S;
    Carcinogenesis; 2010 Apr; 31(4):712-8. PubMed ID: 20083644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
    Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid a as a predictive marker for radiation pneumonitis in lung cancer patients.
    Wang YS; Chang HJ; Chang YC; Huang SC; Ko HL; Chang CC; Yeh YW; Jiang JS; Lee CY; Chi MS; Chi KH
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):791-7. PubMed ID: 22836061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.
    Gao WM; Kuick R; Orchekowski RP; Misek DE; Qiu J; Greenberg AK; Rom WN; Brenner DE; Omenn GS; Haab BB; Hanash SM
    BMC Cancer; 2005 Aug; 5():110. PubMed ID: 16117833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.
    Mayer JM; Raraty M; Slavin J; Kemppainen E; Fitzpatrick J; Hietaranta A; Puolakkainen P; Beger HG; Neoptolemos JP
    Br J Surg; 2002 Feb; 89(2):163-71. PubMed ID: 11856128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.
    Petridou ET; Mitsiades N; Gialamas S; Angelopoulos M; Skalkidou A; Dessypris N; Hsi A; Lazaris N; Polyzos A; Syrigos C; Brennan AM; Tseleni-Balafouta S; Mantzoros CS
    Oncology; 2007; 73(3-4):261-9. PubMed ID: 18424891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma C-reactive protein and risk of cancer: a prospective study from Greece.
    Trichopoulos D; Psaltopoulou T; Orfanos P; Trichopoulou A; Boffetta P
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):381-4. PubMed ID: 16492932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum peptidome profiling in patients with lung cancer.
    Yang J; Yang SY; Hu XY; Huo SF; Shang WL; Li ZF; Ni L; Wang AY; Guo YM; Song TS; Chen-Huang
    Anat Rec (Hoboken); 2010 Dec; 293(12):2027-33. PubMed ID: 21082738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.
    Khan N; Cromer CJ; Campa M; Patz EF
    Cancer; 2004 Jul; 101(2):379-84. PubMed ID: 15241837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
    Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers.
    Ali IU; Xiao Z; Malone W; Smith M; Conrads TP; Veenstra TD; Greenwald P; Luke BT; McLarty JW
    Oncol Rep; 2006 May; 15(5):1367-72. PubMed ID: 16596212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.
    Chen Y; Zhang H; Xu A; Li N; Liu J; Liu C; Lv D; Wu S; Huang L; Yang S; He D; Xiao X
    Lung Cancer; 2006 Oct; 54(1):95-102. PubMed ID: 16890323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.
    Sung HJ; Ahn JM; Yoon YH; Rhim TY; Park CS; Park JY; Lee SY; Kim JW; Cho JY
    J Proteome Res; 2011 Mar; 10(3):1383-95. PubMed ID: 21141971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.